Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable [Phase 2]
Phase 2 clinical trial evaluating tilelizumab with nab-paclitaxel for high-risk non-muscle-invasive urothelial bladder carcinoma that is not…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 safety study of recombinant human hyaluronidase (Chemophase) with mitomycin in superficial bladder cancer has completed; results…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants [Phase 1, Phase 2]
This clinical trial update reports safety and pharmacology results for atezolizumab alone and with BCG in high-risk non-muscle-invasive blad…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]
Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) [Phase 3]
Phase 3 trial of intravesical apaziquone (Qapzola) as a surgical adjuvant during TURBT for bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT) [Phase 3]
Phase 3 trial of intravesical apaziquone as a surgical adjuvant in TURBT for bladder cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer [Phase 1]
Phase Ib feasibility neoadjuvant trial of nivolumab plus lirilumab for cisplatin-ineligible muscle-invasive bladder cancer has completed enr…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) [Phase 3]
Phase 3 EV-301 trial comparing enfortumab vedotin to standard chemotherapy in previously treated locally advanced or metastatic urothelial c…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer [Phase 2]
Phase 2 study investigating RC48-ADC in combination with Triplizumab for myometrial invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder [Phase 2]
Phase 2 trial update on Mycobacterium w for superficial transitional cell carcinoma of the bladder has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy [Phase 2]
Phase 2 clinical trial update for prucalopride aimed at treating postoperative ileus in patients undergoing robot-assisted laparoscopic radi…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy [Phase 2]
A Phase 2 study of pembrolizumab with gemcitabine and cisplatin as neoadjuvant therapy for bladder cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. [Phase 3]
A Phase 3 randomized controlled trial investigating a fast track protocol after radical cystectomy and urinary diversion for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder [Phase 2]
Phase 2 trial of durvalumab (Medi4736) for BCG-refractory urothelial carcinoma in situ of the bladder (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: PF-03446962 in Relapsed or Refractory Urothelial Cancer [Phase 2]
Phase 2 clinical trial of PF-03446962 in relapsed or refractory urothelial cancer (transitional cell carcinoma of the bladder) has completed…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
A completed clinical trial studying perioperative hypogonadism in men undergoing radical cystoprostatectomy for bladder cancer with results …
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder [Phase 2]
A Phase 2 clinical trial update evaluating preoperative Bintrafusp Alfa in operable urothelial carcinoma of the bladder is in progress.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of CG0070 Oncolytic Virus regimen for high-grade non-muscle invasive bladder cancer af…
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer [Phase 2]
Phase II trial evaluating temsirolimus as a second-line therapy in relapsed bladder cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer [Phase 3]
A Phase 3 clinical trial evaluating electromotive mitomycin-C (EMDA-MMC) to prevent recurrences in high-risk non-muscle-invasive bladder can…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Comparison of Obturator Nerve Blockade and Neuromuscular Blockade [Phase 4]
A Phase 4 trial comparing obturator nerve blockade with neuromuscular blockade in cancer of the bladder has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Steps to Eliminate Postoperative Problems [NA]
A completed clinical trial update related to bladder cancer; results posted, details not specified.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating surgery plus combination chemotherapy and radiation therapy for cancer of the urinary tract (bladder cancer and rel…